Coenzyme Q10 was first identified in 1957. Its chemical structure was determined in 1958. Interest in
coenzyme Q10 as a potential treatment for cancer began in 1961, when a deficiency of the enzyme was
noted in the blood of cancer patients. Low blood levels of coenzyme Q10 have been found in patients with
mycelia, lymphoma, and cancers of the breast, lung, prostate, pancreas, colon, kidney, and head and neck